Innate Pharma (IPHA) Receivables - Other (2017 - 2025)
Innate Pharma posted quarterly Receivables - Other of $657684.6 for Q4 2025, up 591.54% year-on-year from $95105.0 in Q4 2024, and up 591.54% on a QoQ basis from $95105.0 in Q4 2024.
Innate Pharma (IPHA) has 9 years of Receivables - Other data on file, last reported at $657684.6 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other rose 591.54% year-over-year to $657684.6; the trailing twelve-month figure through Dec 2025 stood at $657684.6 (up 591.54% YoY), and the FY2025 full-year result was $657684.6, up 591.54% from the prior year.
- Receivables - Other for Q4 2025 stood at $657684.6, up from $95105.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $931192.4 in Q4 2021 and bottomed at $62235.1 in Q4 2022.
- The 5-year median for Receivables - Other is $111897.8 (2023), against an average of $371623.0.
- The widest annual swing landed in 2022, when Receivables - Other slumped 93.32%; it then soared 591.54% in 2025.
- A 5-year view of Receivables - Other shows it stood at $931192.4 in 2021, then plunged by 93.32% to $62235.1 in 2022, then jumped by 79.8% to $111897.8 in 2023, then slipped by 15.01% to $95105.0 in 2024, then jumped by 591.54% to $657684.6 in 2025.
- The last three Receivables - Other figures came in at $657684.6 (Q4 2025), $95105.0 (Q4 2024), and $111897.8 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 136,193.09 |
| Dec 31, 2025 | 136,193.09 |
| Dec 31, 2024 | 95,104.99 |
| Dec 31, 2024 | 95,104.99 |
| Dec 31, 2023 | 111,897.75 |
| Dec 31, 2023 | 111,897.75 |
| Dec 31, 2022 | 62,235.09 |
| Dec 31, 2022 | 62,235.09 |
| Dec 31, 2021 | 931,192.35 |
| Dec 31, 2021 | 931,192.35 |
| Dec 31, 2020 | 883,486.78 |
| Dec 31, 2020 | 883,486.78 |
| Dec 31, 2019 | 602,146.89 |
| Dec 31, 2019 | 602,146.89 |
| Dec 31, 2018 | 123.94 Mn |
| Dec 31, 2018 | 123.94 Mn |
| Dec 31, 2017 | 163,663.12 |
| Dec 31, 2017 | 163,663.12 |